• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类固醇和外源性物质受体及其可能的靶基因——有机阴离子转运多肽-A在人乳腺癌中的表达

Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A, in human breast carcinoma.

作者信息

Miki Yasuhiro, Suzuki Takashi, Kitada Kunio, Yabuki Nami, Shibuya Rie, Moriya Takuya, Ishida Takanori, Ohuchi Noriaki, Blumberg Bruce, Sasano Hironobu

机构信息

Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Miyagi-ken, Japan.

出版信息

Cancer Res. 2006 Jan 1;66(1):535-42. doi: 10.1158/0008-5472.CAN-05-1070.

DOI:10.1158/0008-5472.CAN-05-1070
PMID:16397270
Abstract

Steroid and xenobiotic receptor (SXR) or human pregnane X receptor (hPXR) has been shown to play an important role in the regulation of genes related to xenobiotic detoxification, such as cytochrome P450 3A4 and multidrug resistance gene 1. Cytochrome P450 enzymes, conjugation enzymes, and transporters are all considered to be involved in the resistance of breast carcinoma to chemotherapeutic or endocrine agents. However, the expression of SXR/hPXR proteins and that of its target genes and their biological or clinical significance have not been examined in human breast carcinomas. Therefore, we first examined SXR/hPXR expression in 60 breast carcinomas using immunohistochemistry and quantitative reverse transcription-PCR. We then searched for possible SXR/hPXR target genes using microarray analysis of carcinoma cells captured by laser microscissors. SXR/hPXR was detected in carcinoma tissues but not in nonneoplastic and stromal cells of breast tumors. A significant positive correlation was detected between the SXR/hPXR labeling index and both the histologic grade and the lymph node status of the carcinoma cases. Furthermore, in estrogen receptor-positive cases, SXR/hPXR expression was also positively correlated with expression of the cell proliferation marker, Ki-67. Microarray analysis showed that organic anion transporting polypeptide-A (OATP-A) was most closely correlated with SXR/hPXR gene expression, and both OATP-A mRNA and protein were significantly associated with SXR/hPXR in both breast carcinoma tissues and its cell lines. These results suggest that SXR/hPXR and its target gene, such as OATP-A, may play important roles in the biology of human breast cancers.

摘要

类固醇和外源性物质受体(SXR)或人孕烷X受体(hPXR)已被证明在与外源性物质解毒相关的基因调控中发挥重要作用,如细胞色素P450 3A4和多药耐药基因1。细胞色素P450酶、结合酶和转运蛋白都被认为与乳腺癌对化疗或内分泌药物的耐药性有关。然而,尚未在人类乳腺癌中检测SXR/hPXR蛋白及其靶基因的表达以及它们的生物学或临床意义。因此,我们首先使用免疫组织化学和定量逆转录PCR检测了60例乳腺癌中的SXR/hPXR表达。然后,我们使用激光显微切割捕获的癌细胞微阵列分析来寻找可能的SXR/hPXR靶基因。在癌组织中检测到SXR/hPXR,但在乳腺肿瘤的非肿瘤细胞和基质细胞中未检测到。在癌病例中,SXR/hPXR标记指数与组织学分级和淋巴结状态之间均检测到显著正相关。此外,在雌激素受体阳性病例中,SXR/hPXR表达也与细胞增殖标志物Ki-67的表达呈正相关。微阵列分析表明,有机阴离子转运多肽-A(OATP-A)与SXR/hPXR基因表达最密切相关,并且在乳腺癌组织及其细胞系中,OATP-A mRNA和蛋白均与SXR/hPXR显著相关。这些结果表明,SXR/hPXR及其靶基因,如OATP-A,可能在人类乳腺癌生物学中发挥重要作用。

相似文献

1
Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A, in human breast carcinoma.类固醇和外源性物质受体及其可能的靶基因——有机阴离子转运多肽-A在人乳腺癌中的表达
Cancer Res. 2006 Jan 1;66(1):535-42. doi: 10.1158/0008-5472.CAN-05-1070.
2
The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.STS和OATP - B信使核糖核酸表达在预测人类乳腺癌临床结果中的作用。
Anticancer Res. 2006 Nov-Dec;26(6C):4985-90.
3
Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells.芳香化酶在人乳腺癌组织中的定位:肿瘤内基质细胞与实质细胞之间的可能相互作用。
Cancer Res. 2007 Apr 15;67(8):3945-54. doi: 10.1158/0008-5472.CAN-06-3105.
4
Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor.人乳腺癌中雌激素相关受体α作为一种有效的预后因素。
Cancer Res. 2004 Jul 1;64(13):4670-6. doi: 10.1158/0008-5472.CAN-04-0250.
5
Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma.人乳腺癌中的雌激素磺基转移酶和类固醇硫酸酯酶
Cancer Res. 2003 Jun 1;63(11):2762-70.
6
Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions.过氧化物酶体增殖物激活受体γ在人乳腺癌中的作用:雌激素作用的调节因子
Endocr Relat Cancer. 2006 Mar;13(1):233-50. doi: 10.1677/erc.1.01075.
7
MDR1 gene expression in primary and advanced breast cancer.原发性和晚期乳腺癌中多药耐药基因1(MDR1)的表达
Lab Invest. 1999 Mar;79(3):271-80.
8
[Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].通过结合mRNA差异显示和基因芯片技术鉴定原发性乳腺癌与配对淋巴结转移之间的差异表达基因
Zhonghua Yi Xue Za Zhi. 2006 Oct 24;86(39):2749-55.
9
Evaluation of estrogen receptor alpha and beta and progesterone receptor expression and correlation with clinicopathologic factors and proliferative marker Ki-67 in breast cancers.乳腺癌中雌激素受体α和β以及孕激素受体表达的评估及其与临床病理因素和增殖标志物Ki-67的相关性
Hum Pathol. 2008 May;39(5):720-30. doi: 10.1016/j.humpath.2007.09.019. Epub 2008 Jan 30.
10
17Beta-hydroxysteroid dehydrogenase type 12 in human breast carcinoma: a prognostic factor via potential regulation of fatty acid synthesis.人乳腺癌中17β-羟类固醇脱氢酶12:通过对脂肪酸合成的潜在调控作为一种预后因素
Cancer Res. 2009 Feb 15;69(4):1392-9. doi: 10.1158/0008-5472.CAN-08-0821. Epub 2009 Feb 3.

引用本文的文献

1
Targeting Solute Carrier Transporters (SLCs) as a Therapeutic Target in Different Cancers.将溶质载体转运蛋白(SLCs)作为不同癌症的治疗靶点
Diseases. 2024 Mar 21;12(3):63. doi: 10.3390/diseases12030063.
2
Advances in drug resistance of triple negative breast cancer caused by pregnane X receptor.孕烷X受体导致的三阴性乳腺癌耐药性研究进展
World J Clin Oncol. 2023 Sep 24;14(9):335-342. doi: 10.5306/wjco.v14.i9.335.
3
..
Drug Metab Dispos. 2022 May 29;50(9):1238-50. doi: 10.1124/dmd.121.000704.
4
High Pregnane X Receptor (PXR) Expression Is Correlated with Poor Prognosis in Invasive Breast Carcinoma.高孕烷X受体(PXR)表达与浸润性乳腺癌的不良预后相关。
Diagnostics (Basel). 2021 Oct 20;11(11):1946. doi: 10.3390/diagnostics11111946.
5
Associations between Pregnane X Receptor and Breast Cancer Growth and Progression.孕烷 X 受体与乳腺癌生长和进展的关系。
Cells. 2020 Oct 15;9(10):2295. doi: 10.3390/cells9102295.
6
Post-translational regulation of the major drug transporters in the families of organic anion transporters and organic anion-transporting polypeptides.有机阴离子转运体家族和有机阴离子转运多肽家族中主要药物转运体的翻译后调控。
J Biol Chem. 2020 Dec 11;295(50):17349-17364. doi: 10.1074/jbc.REV120.009132. Epub 2020 Oct 13.
7
Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy-Modulators of Cellular Entry or Pharmacokinetics?SLC21、SLC22A和SLC15A家族的摄取转运体在抗癌治疗中——细胞摄取调节剂还是药代动力学调节剂?
Cancers (Basel). 2020 Aug 12;12(8):2263. doi: 10.3390/cancers12082263.
8
Dechlorination and demethylation of ochratoxin A enhance blocking activity of PXR activation, suppress PXR expression and reduce cytotoxicity.赭曲霉毒素A的脱氯和去甲基化增强了孕烷X受体(PXR)激活的阻断活性,抑制PXR表达并降低细胞毒性。
Toxicol Lett. 2020 Oct 10;332:171-180. doi: 10.1016/j.toxlet.2020.07.012. Epub 2020 Jul 10.
9
Solute transporters and malignancy: establishing the role of uptake transporters in breast cancer and breast cancer metastasis.溶质转运体与恶性肿瘤:摄取转运体在乳腺癌和乳腺癌转移中的作用。
Cancer Metastasis Rev. 2020 Sep;39(3):919-932. doi: 10.1007/s10555-020-09879-6.
10
Novel insights into the organic solute transporter alpha/beta, OSTα/β: From the bench to the bedside.新型有机溶质转运体α/β(OSTα/β)的研究进展:从实验室到临床。
Pharmacol Ther. 2020 Jul;211:107542. doi: 10.1016/j.pharmthera.2020.107542. Epub 2020 Apr 2.